These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38979294)

  • 41. Co-treatment of betulin and gefitinib is effective against EGFR wild-type/KRAS-mutant non-small cell lung cancer by inducing ferroptosis.
    Yan WY; Cai J; Wang JN; Gong YS; Ding XB
    Neoplasma; 2022 May; 69(3):648-656. PubMed ID: 35330996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrative analysis of cancer dependency data and comprehensive phosphoproteomics data revealed the EPHA2-PARD3 axis as a cancer vulnerability in KRAS-mutant colorectal cancer.
    Gunji D; Narumi R; Muraoka S; Isoyama J; Ikemoto N; Ishida M; Tomonaga T; Sakai Y; Obama K; Adachi J
    Mol Omics; 2023 Sep; 19(8):624-639. PubMed ID: 37232035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy.
    Yang M; Davis TB; Pflieger L; Nebozhyn MV; Loboda A; Wang H; Schell MJ; Thota R; Pledger WJ; Yeatman TJ
    BMC Cancer; 2022 Mar; 22(1):256. PubMed ID: 35272617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal Cancer Cells: Implications in Therapy.
    Sinha BK; Bortner CD; Jarmusch AK; Tokar EJ; Murphy C; Wu X; Winter H; Cannon RE
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis.
    Ren Z; Hu M; Wang Z; Ge J; Zhou X; Zhang G; Zheng H
    Front Genet; 2021; 12():672904. PubMed ID: 34434214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients.
    Du S; Zeng F; Sun H; Liu Y; Han P; Zhang B; Xue W; Deng G; Yin M; Cui B
    Bioengineered; 2022 Feb; 13(2):2498-2512. PubMed ID: 35067161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients.
    Shao Y; Jia H; Huang L; Li S; Wang C; Aikemu B; Yang G; Hong H; Yang X; Zhang S; Sun J; Zheng M
    Front Oncol; 2021; 11():711776. PubMed ID: 34249766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening of key genes related to ferroptosis and a molecular interaction network analysis in colorectal cancer using machine learning and bioinformatics.
    Xue F; Jiang J; Kou J
    J Gastrointest Oncol; 2023 Jun; 14(3):1346-1359. PubMed ID: 37435214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kras mutation subtypes distinctly affect colorectal cancer cell sensitivity to FL118, a novel inhibitor of survivin, Mcl-1, XIAP, cIAP2 and MdmX.
    Thangaiyan R; Aljahdali IA; Lent-Moore KY; Liao J; Ling X; Li F
    Am J Transl Res; 2021; 13(7):7458-7474. PubMed ID: 34377229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a ferroptosis-related gene signature predicting recurrence in stage II/III colorectal cancer based on machine learning algorithms.
    Wang Z; Ma C; Teng Q; Man J; Zhang X; Liu X; Zhang T; Chong W; Chen H; Lu M
    Front Pharmacol; 2023; 14():1260697. PubMed ID: 37711170
    [No Abstract]   [Full Text] [Related]  

  • 51. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic insights and therapeutic potential for colorectal cancer: mutation analysis of KRAS gene and efficacy of Oleuropein-conjugated iron oxide nanoparticles.
    Mehdinejad S; Peymani M; Salehzadeh A; Zaefizadeh M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; ():. PubMed ID: 38837069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer.
    Jin H; Zhu M; Zhang D; Liu X; Guo Y; Xia L; Chen Y; Chen Y; Xu R; Liu C; Xi Q; Xia S; Shi T; Zhang G
    Cancer Sci; 2023 Nov; 114(11):4225-4236. PubMed ID: 37661645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis.
    Ming T; Lei J; Peng Y; Wang M; Liang Y; Tang S; Tao Q; Wang M; Tang X; He Z; Liu X; Xu H
    Phytother Res; 2024 Aug; 38(8):3954-3972. PubMed ID: 38837315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.
    Yari A; Samoudi A; Afzali A; Karam ZM; Karimaldini NK; Abadi MFS; Ziasistani M; Zangouey MR; Dabiri S
    J Gastrointest Cancer; 2021 Jun; 52(2):557-568. PubMed ID: 32495109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.
    Luo J; Yu H; Yuan Z; Ye T; Hu B
    Clin Transl Oncol; 2023 Jul; 25(7):2265-2276. PubMed ID: 36820954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1.
    Kandasamy P; Zlobec I; Nydegger DT; Pujol-Giménez J; Bhardwaj R; Shirasawa S; Tsunoda T; Hediger MA
    Mol Oncol; 2021 Oct; 15(10):2782-2800. PubMed ID: 34003553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer.
    Wu W; Zhao Y; Qin B; Jiang X; Wang C; Hu R; Ma R; Lee MH; Liu H; Li K; Yuan P
    EBioMedicine; 2023 Jul; 93():104650. PubMed ID: 37343364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.